There Has Never Been a Better Time to Be an Academic Founder. There Are Also a Few Things We Need to Be Honest About.
Faraz Rizvi is a UK operator-practitioner writing about the work between a research breakthrough and a fundable company. He has worked in early-stage TRL-funded venturing, mentored academics through ICURe and into spinout, served as co-founder and COO of a startup, and led global digital-transformation programmes. He runs SpinUp Forge. Foundry is SpinUp Forge's custom agentic harness.
The founding teams that stall after licence are rarely stalling because the science let them down. They are stalling because nobody told them the job changed. The policy environment is more receptive to spinout formation than it has been in a generation. Funding instruments have evolved. The tool surface available to a founding team has moved in ways nobody was seriously predicting three years ago. The conditions, on paper, are genuinely good. The catch is that a spinout is not another research grant — not resourced like one, evaluated like one, or governed like one — and almost nothing in a founder's training says so.
I have come at this from four angles, each reading the same gap differently. In TRL-funded venturing, the distance between a promising result and a legible investment opportunity is what you stare at every day. Mentoring academic founders through ICURe and into their first months of spinning out, I watched the moment the institutional scaffolding falls away and the actual work begins. Co-founding a startup and running operations was a specific education in the distance between a plan and an operating company. And leading digital-transformation programmes inside larger organisations taught me that the constraint is rarely the technology — it is almost always the procedure. All four angles point at the same place. That is what this series maps.
The gap is easier to read on a time axis than in prose. The diagram below places two qualitative trajectories on the same eighteen-month window — operational debt rising as the science work proceeds, founder attention available declining as that debt accumulates. Line shapes are illustrative; the widening gap is the claim Pieces 1 and 3 anchor to named evidence.
The gap is not the science
The research is the strongest asset most founding teams hold — the artefacts that must follow it are what quietly accumulate and stall the round.
What is actually missing is harder to name and easier to overlook. A technology transfer office (TTO) — the unit inside a university that turns research into licences and companies — is not designed to carry the commercial execution work past licence. The work in question is specific: a board pack that communicates, a financial model that closes the round rather than back-calculates from the number the founders want to raise, a go-to-market sequence with named customers and named owners, a hiring plan for the first non-academic roles. None of those are science problems. None of them fix themselves. They accumulate in the background until they surface in a diligence conversation the founding team was not ready for.
What has changed is what it now costs to stay in that gap. A spinout in 2026 is not competing against the 2023 cohort — it is competing against a cohort operating against a tool surface that is doing work a headcount used to do. The difference shows up before the investor conversation, in the board pack: a founding team running named workflows produces a pre-meeting pack from an overnight bank-feed pull in forty-five minutes; a team without it rebuilds the cash bridge by hand and loses two working days. Same team, same science — the gap is in what surrounds it. That is the opportunity. It is also the new baseline.
Three pieces, one argument
Each piece reads the same gap from a different angle; together they close a single map of what a spinout actually requires in 2026.
You can read each piece on its own. Read as a set, they close one argument.
Piece 1 maps what the UK's R&D architecture actually bought — and what it did not. £58.5 billion committed to R&D over the four years to 2029/30, set against roughly £8 million per year nationally for spinout proof-of-concept support. That ratio is not an accident. Understanding it — what it means for where the system draws its lines, where the gaps are structurally located, what the recent policy moves do and do not address — is the precondition for using the architecture rather than being caught out by it.
Piece 2 makes the case that the bottleneck in 2026 is not the model. The capability question is largely answered. What is not answered — for most founding teams I have spoken with — is whether they have built anything around that capability that still runs next month. METR's own evidence on how fast the tool surface moved since the 2025 RCT is the sharpest available account of how much the landscape shifted in nine months. That movement is the context. The piece is about what to do with it.
Piece 3 sets out what an AI-first operator substrate looks like in practice, and why the survival arithmetic for the first 18 months now depends on it. Not in theory — in the specific, unglamorous, recurring outputs that decide whether a seed-stage company reaches its next investor conversation in good standing: the board pack assembled on time, the financial model that reflects current assumptions, the customer-discovery synthesis that does not decay in a shared folder. The FTE arithmetic lives here, and so does the concrete case for what to build, and in what order.
The map this series builds is not a general map of "AI for founders" — that one exists and is widely distributed. It is a specific map of where the execution gap sits as a company spins out, what it costs when it stays open, what closing it actually requires in 2026, and what the founding teams doing it well are doing differently from those that are not.
Piece 1 starts with the architecture — because understanding what the system was designed to fund is the fastest way to understand what it was not.
← Back to SpinUp Forge